Pembrolizumab‐induced secondary sclerosing cholangitis in a non‐small cell lung cancer patient
Abstract A 50‐year‐old woman with stage IV lung adenocarcinoma received seven cycles of pembrolizumab as third‐line chemotherapy. Following the failure of pembrolizumab, she commenced fourth‐line chemotherapy of docetaxel and ramucirumab. The patient complained of epigastric pain and a computed tomo...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-07-01
|
| Series: | Respirology Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rcr2.560 |